Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Synovics Pharmaceuticals Inc. (SYVC) had Debt to Capital Ratio of 1.63 for the most recently reported fiscal quarter, ending 2009-07-31.
| Income Statement Financials | |
$1.57M |
|
$-2.02M |
|
$2.15M |
|
$-0.58M |
|
$3.42M |
|
$-1.85M |
|
$-0.16M |
|
$-2.02M |
|
$-2.02M |
|
$-2.02M |
|
$-2.02M |
|
$-2.02M |
|
$-2.02M |
|
$-1.85M |
|
$-1.59M |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$4.67M |
|
$3.48M |
|
$15.36M |
|
$18.76M |
|
$17.54M |
|
$1.99M |
|
$1.99M |
|
$19.54M |
|
$-1.61M |
|
$-12.56M |
|
$-0.77M |
|
-- |
|
| Cash Flow Statement Financials | |
$0.74M |
|
$-0.09M |
|
$-0.58M |
|
$0.06M |
|
$0.13M |
|
$0.06M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.27 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
1.63 |
-7.96 |
|
-36.94% |
|
-117.83% |
|
-117.83% |
|
-- |
|
-128.66% |
|
-128.66% |
|
$0.65M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
0.93 |
|
1.02 |
|
88.28 |
|
125.47% |
|
16.08% |
|
-10.77% |
|
-165.57% |
|
-- |
|
-- |
|
-- |
|